On March 25, 2020, Peng Jin resigned from the Board of Directors of Cinedigm Corp., effective immediately, to pursue other personal interests. Mr. Jin was a designee of Bison Entertainment Investment Limited, the Company’s large stockholder, pursuant to designation rights in the Stock Purchase Agreement dated as of June 29, 2017 between Bison and the Company. On March 25, 2020, the Board appointed Tom Bu as a director to fill the vacancy resulting from Mr. Jin’s resignation. Mr. Bu is a designee of Bison in accordance with the Designation Rights, which entitle Bison to designate a new designee in the event that an existing designee fails to complete a term on the Board. Mr. Bu has served as Audit/Financial Director for Bison Finance Group Ltd. (HK00888) since June 2017. From October 2017 through June 2019, he was the Chief Financial Officer of Xynomic Pharmaceuticals Holdings Inc., f/k/a Bison Capital Acquisition Corp. From September 2010 through June 2017, Mr. Bu was an Audit Manager at KPMG Huazhen LLP. Mr. Bu is qualified by The Chinese Institute of Certified Public Accountants.